Nebulized arformoterol, a long-acting β2-adrenergic bronchodilator, in patients with COPD.

被引：0
|
作者：
Baumgartner, Rudolf A. [1 ]
Hanrahan, John P. [1 ]
Sciarappa, Kenneth [1 ]
机构：
[1] Sepracor Inc, Marlborough, MA USA
来源：
CRITICAL CARE MEDICINE | 2006年 / 34卷 / 12期
关键词：
D O I：
10.1097/00003246-200612002-00329
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
348
引用
收藏
页码：A95 / A95
页数：1
相关论文
共 50 条
  • [31] Use of a long-acting inhaled β2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease
    Rennard, SI
    Anderson, W
    ZuWallack, R
    Broughton, J
    Bailey, W
    Friedman, M
    Wisniewski, M
    Rickard, K
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (05) : 1087 - 1092
  • [32] Use of controller medications in patients initiated on a long-acting β2-adrenergic agonist before and after safety alerts
    Stockl, Caren A.
    Le, Lisa
    Harada, Ann S. M.
    Zhang, Shaoang
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (16) : 1533 - 1538
  • [33] Comparative Effectiveness Of Tiotropium Compared To No Long-Acting Bronchodilator After A Hospitalization For COPD
    Roberts, M. H.
    Mapel, D. W.
    Petersen, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [34] Which long-acting bronchodilator is most cost-effective for the treatment of COPD?
    Hoogendoorn, M.
    Kappelhoff, B. S.
    Overbeek, J. A.
    Wouters, E. F. M.
    Rutten-van Molken, M. P. M. H.
    NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (08): : 357 - 364
  • [35] CLENBUTEROL (SPIROPENT) - A LONG-ACTING BRONCHODILATOR
    WHEATLEY, D
    CURRENT MEDICAL RESEARCH AND OPINION, 1982, 8 (02) : 113 - 119
  • [36] Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
    Halpin, David M. G.
    Kerkhof, Marjan
    Soriano, Joan B.
    Mikkelsen, Helga
    Price, David B.
    RESPIRATORY RESEARCH, 2016, 17
  • [37] Role of long-acting β2-adrenergic agonists in asthma management based on updated asthma guidelines
    Prenner, Bruce M.
    CURRENT OPINION IN PULMONARY MEDICINE, 2008, 14 (01) : 57 - 63
  • [38] Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
    David M. G. Halpin
    Marjan Kerkhof
    Joan B. Soriano
    Helga Mikkelsen
    David B. Price
    Respiratory Research, 17
  • [39] Effect of β2-adrenergic receptor gene (ADRB2) 3′ untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist response
    Ambrose, Helen J.
    Lawrance, Rachael M.
    Cresswell, Carl J.
    Goldman, Mitchell
    Meyers, Deborah A.
    Bleecker, Eugene R.
    RESPIRATORY RESEARCH, 2012, 13
  • [40] Effect of β2-adrenergic receptor gene (ADRB2) 3′ untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist response
    Helen J Ambrose
    Rachael M Lawrance
    Carl J Cresswell
    Mitchell Goldman
    Deborah A Meyers
    Eugene R Bleecker
    Respiratory Research, 13
12345